PFBC

Preferred Bank

Nasdaq· CIK 0001492165

$106.72 −1.90 (−1.75%)

Oct 23 4:00 PM ET · prev $108.62

Market cap

$1.6B

Small cap

Consensus

Buy

58% Buy or better · 12 analysts

Median target

🔒 Subscribers only

1 year

+14.6%

from $93.09 · Oct 24

30 days

−1.7%

from $108.58

52-week range

$82.72–109.48

−3% from high · low Jan 28

Avg volume 20D

128.3K

Sep 29 spike 324.3K

Short interest

1.34M

≈9.4% of shares · +9.4%

Days to cover

6.0

at average volume

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BEARISH 2 reports · 90 days

Balance 1 bearish · 0 bullish · 1 neutral oldest → newest, height = score

Avg score

·High conf. 2/2

Strongest BEARISH Preferred Bank (PFBC) reported Q3 2026 EPS of $2.73, a modest 1.6% beat vs. the $2.69 consensus, but net…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

InstitutionsMIXED

Q2 2026: 12 added (0 new), 10 trimmed or exited.
AnalystsBULLISH

7 of 12 rate it Buy or better.
Short sellersSTEADY

Short interest +9.4% to 1.34M shares. 6.0 days to cover, ≈9.4% of shares.
TrendRANGE

2% above its 50-day average.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
CITADEL ADVISORS LLC	TRIM	64,837	$6.9M
JPMORGAN CHASE & CO	ADD	42,072	$4.5M
D. E. Shaw & Co., Inc.	ADD	40,979	$4.4M
FIRST TRUST ADVISORS LP	TRIM	38,433	$4.1M
Russell Investments Group, Ltd.	ADD	18,250	$1.9M
BNP PARIBAS FINANCIAL MARKETS	DOUBLED	15,356	$1.6M
CITIGROUP INC	ADD	15,300	$1.6M
Quantinno Capital Management LP	DOUBLED	14,461	$1.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12 analysts

Buy 58% rate it Buy or better

Strong Buy2Buy5Hold5Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access

Recent actions

Date	Firm	Action	Rating
Oct 1, 2026	Piper Sandler MAINTAIN	MAINTAIN	Overweight
Sep 24, 2026	StoneX INITIATE	INITIATE	Buy
Jul 23, 2026	Stephens & Co. MAINTAIN	MAINTAIN	Equal-Weight

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data — subscribers only
Next Q	🔒 Fresh data — subscribers only
Current FY	🔒 Fresh data — subscribers only
Next FY	🔒 Fresh data — subscribers only

Catalysts

Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.

Recent

Oct 23, 2026

Earnings

Preferred Bank Reports Third Quarter Results

LOS ANGELES, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Preferred Bank (NASDAQ: PFBC) , one of the larger independent California banks, today reported…

Oct 23, 2026

Earnings result

PFBC Q3 2026 Earnings: EPS $2.73 (-0.4% vs est)

Oct 14, 2026

FDA

Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05

Class II: Failed Content Uniformity Specifications

Sep 29, 2026

FDA

Temazepam

WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS • Concomitant use of benzodiaz

Sep 16, 2026

Dividend

Preferred Bank Announces Quarterly Dividend

LOS ANGELES, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Preferred Bank (NASDAQ: PFBC) , one of the larger independent commercial banks in California, today…

Short side

FINRA· Sep 30, 2026

1,344,593

shares short

+9.4%

vs prior settlement

6.0

days to cover

≈9.4%

of shares outstanding

Recent activity

The latest filings, insider trades, analyst actions, press and options flow — newest first.

Oct 23, 2026 SEC

Preferred Bank (PFBC) reported Q3 2026 EPS of $2.73, a modest 1.6% beat vs. the $2.69 consensus, but net income…

PRESS-RELEASE — Impact 5/10

Oct 23, 2026 Earnings

Preferred Bank Reports Third Quarter Results

LOS ANGELES, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Preferred Bank (NASDAQ: PFBC) , one of the larger ind

Oct 14, 2026 Event

Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05

Class II: Failed Content Uniformity Specifications

Sep 16, 2026 Press

Preferred Bank declared a quarterly cash dividend of $0.80 per share, payable on October 19, 2026. This is a routine…

Impact 2/10

Jul 22, 2026 SEC

Preferred Bank (PFBC) reported Q2 2026 diluted EPS of $2.78, beating the $2.65 consensus by 4.9%, while total revenue…

PRESS-RELEASE — Impact 6/10

Jul 9, 2026 SEC

Preferred Bank announced it will report its Q2 2026 results on July 22, 2026.

PRESS-RELEASE — Impact 1/10

Jun 30, 2026 Inst.

CITADEL ADVISORS LLC — TRIM